pI: 9.6227 |
Length (AA): 489 |
MW (Da): 59001 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
152 | 331 | 4uos (A) | 7 | 185 | 9.00 | 0 | 0.02 | 0.566898 | -1.85 |
209 | 361 | 5cwj (A) | 3 | 159 | 31.00 | 0.025 | 1 | 0.703983 | -1.23 |
215 | 310 | 1w9r (A) | 15 | 117 | 34.00 | 0.32 | 0.28 | 0.455419 | -0.13 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | epimastigote, metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_129329)
Species | Accession | Gene Product |
---|---|---|
Drosophila melanogaster | Dmel_CG17230 | CG17230 gene product from transcript CG17230-RA |
Echinococcus granulosus | EgrG_000178600 | trichoplein keratin filament binding protein |
Echinococcus multilocularis | EmuJ_000178600 | trichoplein keratin filament binding protein |
Giardia lamblia | GL50803_16013 | Spindle pole protein, putative |
Homo sapiens | ENSG00000139437 | trichoplein, keratin filament binding |
Homo sapiens | ENSG00000172361 | cilia and flagella associated protein 53 |
Leishmania braziliensis | LbrM.23.1690 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_231850.1 | Tumour suppressor, Mitostatin, putative |
Leishmania infantum | LinJ.23.1850 | hypothetical protein, conserved |
Leishmania major | LmjF.23.1450 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.23.1450 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000035394 | cilia and flagella associated protein 53 |
Mus musculus | ENSMUSG00000002486 | trichoplein, keratin filament binding |
Neospora caninum | NCLIV_034180 | hypothetical protein, conserved |
Schistosoma japonicum | Sjp_0015500 | expressed protein |
Schistosoma japonicum | Sjp_0015520 | Trichoplein keratin filament-binding protein, putative |
Schistosoma japonicum | Sjp_0206900 | expressed protein |
Schistosoma mansoni | Smp_180580 | meiosis-specific nuclear structural protein 1 |
Schistosoma mansoni | Smp_174880 | FOG precursor |
Schmidtea mediterranea | mk4.001488.00 | |
Trypanosoma brucei gambiense | Tbg972.5.1700 | T. brucei spp.-specific protein |
Trypanosoma brucei | Tb927.5.1230 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_5_1170 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509767.150 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509601.150 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_273468 | hypothetical protein |
Trichomonas vaginalis | TVAG_436250 | coiled-coil domain-containing protein, putative |
Trichomonas vaginalis | TVAG_023280 | coiled-coil domain-containing protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.1230 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.1230 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.1230 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.1230 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_273468 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_273468 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.